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EVIDENCE COLLECTION METHODOLOGY:
We began the preparation of this guideline with the training of the 
authors using the methodology employed by the Oxford Centre for 
Evidence-Based Medicine, for the development of clinical guidelines 
for the Programa Diretrizes da Associação Médica Brasileira-AMB 
(Brazilian Medical Association’s Guideline Program-BMA).
Articles were reviewed from the MEDLINE (PubMed) database and 
other research sources, on an open-ended basis. The search strategy 
used was based on structured questions in the P.I.C.O. form (from the 
initials of “Patient”, “Intervention”, “Control”, and “Outcome”).
The following are the search parameters for rotator cuff syndrome:
QUESTION 1: (Rotator Cuff or shoulder pain or shoulder impingement) 
AND (analgesics OR paracetamol OR acetaminophen OR dipyrone)
QUESTION 2: (Rotator Cuff or shoulder pain or shoulder 
impingement) AND (muscle relaxants OR cyclobenzaprine OR diazepam 
OR benzodiazepines OR carisoprodol OR tizanidine OR tetrazepam)
QUESTION 3: (Rotator Cuff OR shoulder pain OR shoulder 
impingement OR tendinopathy) AND (Anti-Inflammatory Agents, 
Non-Steroidal OR NSAIDs OR aspirin OR indomethacin OR diclofenac 
OR piroxicam OR tenoxicam OR meloxicam OR phenylbutazone OR 
ibuprofen OR naproxen OR nimesulide OR Cyclooxygenase 2 Inhibitors 
OR valdecoxib OR celecoxib OR etoricoxib)
QUESTION 4: (Rotator Cuff or shoulder pain or shoulder 
impingement) AND (Opioids or Narcotics or Morphine or Oxymorphone 
or Hydromorphoneor Tapentadol or Morphine derivates or Oxycodone 
or Hydrocodone or Fentanyl or Tramadol or Codeine or Buprenorphine 
or Methadone or Dextropropoxyphene)
QUESTION 5: (shoulder impingement syndrome OR rotator cuff OR 
tendinopathies OR shoulder pain) AND (antidepressant OR duloxetine 
OR venlafaxine OR amitriptyline OR nortriptyline OR clomipramine 
OR imipramine OR desvenlafaxine OR fluoxetine OR sertraline OR 
citalopram OR mirtazapine OR paroxetine OR tryciclic antidepressant 
OR dual antidepressant OR desipramine OR flufenazin OR bupropion 
OR escitalopram)
QUESTION 6: (Shoulder impingement syndrome OR rotator 
cuff OR tendinopathies OR shoulder pain) AND (Anticonvulsant 
Drugs OR Drugs, Anticonvulsant OR Anticonvulsive Drugs OR Drugs, 
Anticonvulsive OR Anticonvulsive Agents OR Agents, Anticonvulsive 
OR Antiepileptic Agents OR Agents, Antiepileptic OR Antiepileptic 
Drugs OR Drugs, Antiepileptic OR Antiepileptics OR zonisamide OR 
topiramate OR lamotrigine OR vigabatrin OR tiagabine OR pregabalin 
OR gabapentin OR valproate OR divalproate OR acid, valproic OR 
benzodiazepine OR carbamazepine OR phenytoin OR phenobarbital 
OR primidone)
QUESTION 7: (Rotator cuff OR tendinopathies OR shoulder pain OR 
shoulder impingement syndrome) AND (acupuncture OR electroacu-
puncture OR moxibustion OR acupoint OR acupoints)
QUESTION 8: (Rotator cuff OR tendinopathies OR shoulder 
pain OR shoulder impingement syndrome) AND (needle or needling 
or needles or hypodermic needles or Hypodermic needle or dry 
needling)
QUESTION 9: Rotator Cuff AND (Anesthetics, Local OR injections, 
intra-articular)
QUESTION 10: (Rotator Cuff OR Tendinopathy OR Shoulder Pain OR 
Shoulder Impingement) AND Myofascial Pain Syndromes)
QUESTION 11: (Rotator cuff OR tendinopathies OR shoulder pain 
OR shoulder impingement syndrome) AND (Anesthetics, Local OR 
Nerve Block OR Myofascial Pain Syndromes)
QUESTION 12: (Rotator Cuff OR Shoulder Impingement Syndrome) 
AND (Exercise Therapy OR Exercise OR Proprioception)
QUESTION 13: (Rotator cuff OR tendinopathies OR shoulder 
pain OR shoulder impingement syndrome) AND (Extracorporeal 
shock wave therapy OR extracorporeal shock wave therapy)
QUESTION 14: (Rotator cuff OR tendinopathies OR shoulder pain 
OR shoulder impingement syndrome) AND (bandages OR kinesiotaping 
OR athletic tape)
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QUESTION 15: (Rotator cuff or shoulder pain or shoulder impinge-
ment syndrome or shoulder impingement) AND (orthotic devices or 
orthosis or orthoses or orthotic or braces or brace or splints or splint 
or casts, surgical or cast)
QUESTION 16: (Rotator cuff OR tendinopathies OR shoulder 
pain OR shoulder impingement syndrome) AND (postoperative or 
post-operative or post operative or postoperative care or post-operative 
care or post operative care or postoperative period or post-operative 
period or post-operative period or postoperatory or post-operatory or 
post operatory or postoperatory care or post-operatory care or post 
operatory care or postoperatory period or post-operatory period or 
post operatory period or rehabilitation)
These descriptors were used as correlations according to the 
proposed theme of the PICO questions. After analyzing this material, 
articles relative to the questions were selected that yielded evidence 
on which to base the present guideline.
QUALITY OF EVIDENCE AND STRENGTH OF RECOMMENDATIONS:
A: Experimental or observational studies of high quality.
B: Experimental or observational studies of lesser quality.
C: Case studies (uncontrolled studies).
D: Opinion with no critical evaluation, based on consensuses, 
physiological studies or animal models.
OBJECTIVE:
To offer information on the treatment of rotator cuff syndrome.
PROCEDURES:
Therapeutic interventions to rehabilitate the main clinical 
manifestations that impair the quality of life, functionality, and 
daily life activities of patients with dystonia.
CONFLICT OF INTERESTS:
The authors have no conflicts of interest to declare.
INTRODUCTION
Shoulder problems are the third most frequent disorder of 
the musculoskeletal system - after problems in the lumbar and 
cervical regions.1 In the general population, there is an estimated an 
annual incidence of 7%2 and annual prevalence of 5% to 47%, and 
approximately 40% of the cases become chronic.2 The prevalence of 
shoulder pain combined with a restricted range of movement due to 
pain impairs the execution of daily life activities and afflicts 20% of the 
general population.4,5 Based on a broad review made in the United 
Kingdom on shoulder pathologies, pain is responsible for an estimated 
cost to society of about 100 million pounds.2
The incidence of joint pain increases with age.6 Thus, with an aging 
population, the number of patients with complaints of shoulder pain 
and consequent impairment tends to grow.
The socio-economic impact of shoulder pathologies is considerable: 
it reaches an economically active population and, for the elderly, it 
adds and/or causes dependence on third parties, which represents a 
high cost to society.
Rotator cuff injuries (RCI) are very prevalent among the causes of 
shoulder pain, including tendinitis and partial and total ruptures of the 
cuff tendons.
This guideline proposes to include adult and elderly patients in 
acute and chronic phases of the rotator cuff syndrome-that is, patients 
with shoulder pain for approximately 6 weeks caused by injuries to the 
rotator cuff.
Studies were excluded from this work if they concerned 
post-surgical patients with no proposal of rehabilitation, if they were 
athletes, or if they had: impact syndrome, osteoarthritis, rheumatoid 
arthritis, fracture, neuropathy, pain not in the shoulder or attributed 
to the rotator cuff, luxation or sub-luxation, and painful shoulder after 
a stroke.
THERAPEUTIC SESSION
1. Is it recommended to use simple oral analgesics in the treatment 
of rotator cuff syndrome?
In the literature, there are no randomized studies or case series 
that recommend the use of simple analgesics, however, it is a broadly 
used medication in clinical practice for rotator cuff pain in acute phases 
or in the worsening of chronic pain from slight to moderate, or in 
association with other classes of medication. The most commonly used 
medications are Paracetamol with the usual dosage of 500-750 mg and 
Dipyrone from 500 mg to 1 g, every 6 hours, and they can be combined. 
In case there is no improvement with the use of such medications, it 
is recommended to stagger the dosage based on the World Health 
Organization (WHO) (D) scale.
recommendation
It is recommended to use simple analgesics such as paracetamol 
with the usual dosage of 500-750 mg, or dipyrone from 500 mg to 
1 g, every 6 hours, or a combination of both in the treatment of 
acute pain or in the worsening of chronic pain related to rotator cuff 
syndrome (D).
2. Is it recommended to use muscle relaxants in the treatment 
of rotator cuff syndrome?
In the literature, there are no randomized studies or case series 
that recommend the use of muscle relaxants, however, it is a broadly 
used medication in the clinical practice when there are associated 
symptoms of myofascial pain syndrome. The most used medications 
are cyclobenzaprine in the dosage from 5 to 10 mg once a day up 
to every 12 hours, but there are side effects that limit the therapy: 
sleepiness, dry mouth, and dizziness. To avoid sleepiness during the 
day, it is recommended to take the medication 2 or 3 hours before 
bedtime. A dose of carisoprodol of up to 350 mg a day is also used, 
phenylbutazone 200 mg every 12 hours or up to every 8 hours, and 
thiocolchicoside in a single dose of 4 mg or up to every 6 hours. These 
medications are normally found in association with analgesics (D).
recommendation
The use of muscle relaxants for rotator cuff syndrome with 
associated painful myofascial symptoms is recommended. In clinical 
practice, 5 to 10 mg of cyclobenzaprine is used once a day or every 
12 hours, with the limiting factor being the side effects of sleepiness, 
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dry mouth, and dizziness. It is also recommended to use a single 
dose of 350 mg of carisoprodol a day, 200 mg of phenylbutazone 
every 12 hours or even every 8 hours, and thiocolchicoside in a single 
dose of 4 mg or even every 6 hours (D).
3. What is the effectiveness of using anti-inflammatory drugs 
in the treatment of rotator cuff syndrome?
The use of non-steroidal anti-inflammatories (NSAIDs) orally or 
locally is effective in the relief of pain associated with tendinopathies 
in the short term (7 to 14 days); however, in patients with longer-term 
or more serious symptoms, there is less chance of success using an 
NSAID.7 The use of Celecoxib with an initial dose of 600 mg, followed 
by 200 mg a day, for 14 days reduces approximately 30% (p < 0.05) 
of the pain. Celecoxib and Naproxen at 500 mg a day are similar in 
reducing pain, but the pain reduction occurs one day before when 
compared to Celecoxib8 (B). The use of 100 mg of Nimesulide, twice 
a day for 14 days to treat acute shoulder pain in adult patients 
reduces the value of the total score of symptoms by approximately 
70% (p < 0.05; IC 95%)9 (B). The use of 100 mg of Nimesulide twice 
a day has a better risk/benefit ratio for safety and tolerance, but 
efficacy similar to other NSAIDs10 (B).
In addition, we indicate 400 mg of Celecoxib a day for 14 days 
for acute shoulder pain to reduce up to 70% of pain while at rest 
and in the recovery of function11 (B). Thus, many NSAIDs have 
shown effectiveness in the control of acute shoulder pain. The 
use of Nimesulide or Naproxen for shoulder tendinitis and bursitis 
after 14 days reduces movement pain by 70%. The use of 7.5 to 
15 mg of Meloxicam or 20 mg of Piroxicam a day for 7 days reduces 
movement pain11 similarly (B). The record of efficacy and safety 
between the different NSAIs is similar. The most common side effects 
are cephalea, dyspepsia, and nausea.
recommendation
The use of NSAIDs is recommended for acute pain associated 
with symptoms of rotator cuff tendinitis and bursitis. They promote 
reduction of pain while at rest or in movement, and help to restore 
function with similar efficacy, for example: Celecoxib - 400 mg a day or 
an initial dose of 600 mg followed by 200 mg a day, Naproxen - 500 mg 
a day, Nimesulide - 100 mg twice a day for 14 days, Meloxicam - 7.5 to 
15 mg, or Piroxicam - 20 mg of a day for 7 days (B).
4. Is the use of opioids effective in the treatment?
Early mobilization after shoulder surgery plays a vital role in 
successful functional rehabilitation. Nevertheless, post-surgical pain 
many times reduces or even impedes the efficacy of physiotherapy.
To perform physiotherapy in the first 72 hours after open 
shoulder surgery, the analgesia controlled by the patient through 
interscalene technique (PCISB) using Ropivacaine at 0.2% (10 mg/h 
as a limit) and maximum daily dose of 450 mg, via interscalene 
catheter, reduces pain while at rest, at 6 hours (p < 0.001), 24 h 
(p = 0.044), and 72 h (p = 0.013), and pain during physiotherapy 
48 hours post-surgery (p = 0.016), being superior to the use of 
patient-controlled intravenous opioid analgesics (PCA), with a bolus 
of 2 mg of Piritramide, with maximum daily dose of 30 mg, for the 
first 72 hours after surgery. Both techniques improve functionality 
similarly when evaluated by the Constant scale12 (B).
recommendation
For early rehabilitation after open shoulder surgery, the use of 
patient controlled analgesia using opiates with a maximum daily dose of 
30 mg or patient controlled analgesia using an interscalene anesthetic 
infusion are similar in improving functionality, however, the interscalene 
technique with Ropivacaine injection at 0.2% to a maximum of 10 mg/h, 
and maximum daily dose of 450 mg, reduces pain at rest for up to 
72 hours and during physiotherapy for 48 hours (B).
5. Is the use of antidepressants effectivein the treatment of 
rotator cuff syndrome?
There are no studies in the literature showing the use of 
antidepressants to treat rotator cuff syndrome, however, in clinical 
practice this class of medication is used in patients with chronic 
musculoskeletal and/or neuropathic pain (D).
Tricyclic antidepressants in low doses are used, and their dosage 
can be gradually increased if there are associated humor or sleep 
disorders. The initial dose used of Amitriptyline is 12.5 to 25 mg or 10 
to 25 mg of Nortriptyline at night. Nortriptyline is mostly indicated for 
the elderly for it causes less postural hypotension. It is also common to 
use 25 mg of Imipramine or Clomipramine at night (D).
The antidepressants that inhibit the reuptake of serotonin and 
norepinephrine such as Duloxetine and Venlafaxine can also be used. 
Duloxetine is used at 30 to 60 mg a day and Venlafaxine from 37.5 to 
150 mg (D).
recommendation
In patients with chronic musculoskeletal and/or neuropathic 
pain, low doses of tricyclic antidepressants are recommended: initial 
dose of Amitriptyline from 12.5 to 25 mg or Nortriptyline from 10 to 
25 mg, at night. Nortriptyline is mostly recommended for the elderly 
for it causes less postural hypotension. Imipramine or Clomipramine 
can also be used, dosed at 25 mg at night. Antidepressants are 
also recommended that inhibit the reuptake of serotonin and 
norepinephrine such as Duloxetine from 30 to 60 mg a day and 
Venlafaxine from 37.5 to 150 mg a day (D).
6. Is the use of anticonvulsants effective in the treatment of 
rotator cuff syndrome?
The dose of 300 mg of Gabapentin every 12 hours for 48 hours 
has shown significant reduction of pain (p 0.02) in patients after 
arthroscopic surgery to repair the rotator cuff,13 although the results 
are controversial14 (B). When there is chronic musculoskeletal pain 
associated or not with neuropathic pain with no response to a previous 
treatment with analgesics and/or anti inflammatory medication, then 
treatment with Gabapentin at the minimum dose of 300 mg every 
8 hours can be considered in order to diminish the allodynia caused 
by the central hypersensitization of pain, and in addition, 200 mg of 
Carbamazepine starting once a day up to every 8 hours (D).
recommendation
The use of 300 mg of Gapentin every 12 hours for 48 hours to 
reduce pain after surgery to repair the rotator cuff arthroscopically 
is recommended (B). For symptoms of chronic musculoskeletal pain 
associated or not with neuropathic pain and/or allodynia caused by 
the central hypersensitization of pain, with no response to a previous 
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treatment with analgesics and/or anti inflammatory medication, 
Gabapentin is used at the minimal dose of 300 mg every 8 hours 
or 200 mg of Carbamazepine starting at once a day and up to every 
8 hours (D).
7. Is acupuncture effective in the treatment of rotator cuff 
syndrome?
Fifteen sessions of acupuncture applied by qualified 
professionals in accordance with the location of pain (anterior: P1, 2; 
anterolateral: LI4, LI11, LI14, and LI15; lateral: TE5, TE13, and TE14; 
posterior: SI3 and SI9) associated with 1-3 Ah-shi points (GB34, 
ST38, and BL58) reduce 50% of the pain in 65% of the patients 
(CI95% 56-74%) after 3 months from the beginning of treatment, 
being superior to conventional treatment with 50 mg of diclofenac 
a day associated to 15 physiotherapy sessions, physical exercises, 
thermotherapy, ultrasound or TENS (p < 0.001, NNT 3, RRR 44% 
CI95% 29 to 59%, RAR 0.31) and to the placebo (p < 0.001, NNT 5, 
RRR 34% CI95% 15-52%, RAR 0.20). There were no adverse effects 
observed in this intervention15 (A).
Two weekly sessions of acupuncture in the LI15, TE14, SI19, 
SI10-13, BL41-46 points and 4 Ah-shi points combined with an 
anti-inflammatory diet of fish, fruit, vegetables, nuts, and grains, 
plus 2 pills composed of 90 mg of bromelain, 48 mg of trypsin, and 
100 mg of rutin three times a day provided a reduction in pain and 
improved the functionality measured by the Shoulder Pain and 
Disability Index, which is superior to conventional therapy of 30 
minutes weekly after 12 weeks of treatment (-29.7; CI95% -42.35 a 
-16.98, p < 0.0001)16 (A).
Acupuncture is also recommended for its lasting effects, which 
are perceptible as much in the area of pain as in the quality of life 
(p < 0.01). Ten acupuncture sessions improve, for up to 3 years, the 
quality of sleep (p < 0.01), reduce depression (p = 0.04), and anxiety 
and irritability (p = 0.02), in addition to pain reduction related to 
domestic chores (p = 0.03), and work (p = 0.04)17 (A). Auriculotherapy 
shows little effect, however it is perceptible for up to 3 months (D).
recommendation
Fifteen sessions of classic acupuncture are recommended twice 
a week to reduce pain and to improve functionality and associated 
symptoms (anxiety, depression, irritability, and quality of sleep) in 
the rotator cuff syndrome. The points used were: LI4, LI11, LI14, LI15, 
P 1,2, TE5, TE13, TE14, SI3, SI9, SI10-13, SI19, GB34, ST38, BL41-46, 
BL58, and Ah-shi points. Auriculotherapy shows little effect, however 
it is perceptible for up to 3 months (D).
8. Is the dry needling effective in the treatment of rotator 
cuff syndrome?
For patients with myofascial pain syndrome of the infraspinal 
muscle and shoulder pain, dry needling of trigger points of that 
muscle showed an immediate reduction of pain measured by the 
VAS (7.8 ± 1.2 to 2.8 ± 1.1) and improvement of range of movement 
measured by goniometry of the treated shoulder - active range 
(from 47.5º ± 16.4º to 70.7º ± 16.5º (p < 0.01)) and passive (from 
51.8º ± 15.5º to 77.5º ± 15.3º (p < 0.01)). However, the duration of 
the effects shown by this procedure is unknown18 (B).
recommendation
To treat shoulder pain combined with myofascial pain syndrome 
of the infraspinal muscle, dry needling of the muscle’s trigger points 
is recommended, for immediate pain reduction and improvement 
of range of movement (B). More studies are needed to verify the 
duration of these effects in the short and long terms.
9. What is the benefit of intra-articular and subacromial 
infiltration in the rotator cuff syndrome?
One single intra-articular corticoid infiltration with anesthetic 
(0.5 ml of triamcinolone at 40 mg/ml, 3.5 ml of bupivacaine at 5 
mg/ml, and 3 ml of physiological solution) increases the range of 
movement by 32º and reduces the pain by 80% (p < 0.01) if applying 
3.5 ml in the glenohumeral articulation, 2.5 ml in the subacromial 
space, and 1 ml in the acromioclavicular articulation, after local 
anesthesia with 0.5 ml of prilocaine and combined with exercises 
(stretching, pulley, Codman exercises, fingerladder). Although 15 
sessions of TENS (transcutaneous electrical nerve stimulator) in 
the anterior and posterior regions of the shoulder for 30 minutes, 
five times a week with 100 Hz, 15 mA, and a 150 µsn amplitude, 
associated to the same exercise program reduces pain and improves 
the amplitude of movement (p < 0.001). Articular infiltration is 
better than TENS at reducing pain for up to 12 weeks after treatment 
(p < 0.05)19 (A).
A local corticoid subacromial infiltration guided by ultrasound 
(2 ml solution of 10 mg/ml of triamcinolone with 5 ml of 10 mg/ml 
of lidocaine) combined with a 4 ml lidocaine injection in the high 
gluteus region for systemic absorption, reduces the pain by 45% and 
lessens impairment (p < 0.001). In the same way, the application 
of a corticoid in the gluteus region for systemic absorption (2 ml of 
triamcinolone with 2 ml of lidocaine) associated with subacromial 
infiltration of 5 ml of lidocaine reduces the pain by 37% (p < 0.001). 
The adverse effects observed were slight, such as flushing, dizziness, 
and the sensation of heat20 (A). There was one report of flushing and 
hoarseness that appeared within 24 hours after the procedure and 
disappeared spontaneously, the former in 2-3 hours and the latter in 
48 hours.21 (C).
In elderly patients with rotator cuff syndrome and no indications 
for surgery, one single corticosteroid articular infiltration (40 mg of 
triamcinolone), or repeated after 21 days associated with 15 sessions 
of 20 minutes of passive mobilization of the glenohumeral 
articulation and stretches for cuff muscles, reduces pain during 
movement by more than 45% and night pain for up to 6 months from 
the application22 (B).
A corticoid subacromial injection improves the range of 
movement in shoulder abduction (average difference of angles: 
35o - CI95%: 14-55), however, it did not show any benefit to the 
range of movement when associated with an oral anti-inflammatory 
(CI95%: -14 to 22) or pain (-11 to 7)23 (A).
A corticoid subacromial injection improves rotator cuff tendinitis 
with relative risk of 3.08 (CI95%: 1.94-4.87) being necessary to 
treat 3.3 patients (CI95%: 1.8-7.7) to obtain improvement in one 
patient (CI 95%: 1.8-7.7). The use of high doses of corticosteroids 
(dose of 50 mg or more of prednisone) showed a more important 
improvement with relative risk of 5.9 (CI95%: 2.8-12.6). In addition, 
the corticosteroid infiltration improves as much as the infiltration 
with non-steroidal anti inflammatory medication with relative 
risk of 1.43 (CI95%: 0.95-2.16) needing 2.5 patients treated with 
corticosteroid in relation to anti inflammatory medication for one 
patient to improve (CI95%: 1-9)24 (A).
A corticoid subacromial infiltration of anesthetic (6 mg of 
betamethasone combined with 4 ml of Xylocaine at 2% with no 
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vasoconstrictor) as well as an isolated anesthetic (5 ml of Xylocaine 
at 2%) in adult patients with therapeutic failure after 2 weeks of using 
non-hormonal anti-inflammatories and 6 weeks of physiotherapy 
was effective for improving the quality of life of the patients for 
up to 6 months after application25 (A). A subacromial infiltration of 
2.5 ml of sodium hyaluronate (25 mg), when applied once a week 
for 5 weeks improves shoulder function by 28% (measured on the 
Constant scale) for up to 6 weeks after the end of the treatment26 
(A) or 2 ml of sodium hyaluronate (10 mg/ml) once a week for 5 
weeks with an improvement in pain of 27% for up to 17 weeks after 
treatment (p = 0.001)27 (B).
As much by anteromedial as by posterior, infiltration can be 
done blindly by an experienced orthopedist if there is a positive 
correlation with the area indicated by Magnetic Resonance Imaging 
66% of the time28 (A). Also, subacromial infiltration done blindly or 
guided by ultrasound have equal accuracy29 (B).
recommendation
Subacromial infiltration can be done with hormonal or 
non-hormonal anti-inflammatories, sodium hyaluronate, or 
anesthetic and effectively reduce pain, range of motion, and 
functionality with the best improvement if used with doses of 
prednisone of more than 50 mg(A). Subacromial infiltration with 
corticoids combined with gluteal injections of anesthetic or a 
subacromial infiltration of anesthetic and a gluteal infiltration 
of corticoid can be recommended to improve the pain and the 
disability, with no difference as to local or systemic absorption of 
the corticoids. Among aging people with no surgical prescription, 
the intra-articular infiltration can be applied in a single session or 
repeated in 21 days in conjunction with 15 sessions of 20 minutes 
of passive mobilization of the glenohumeral joint and stretching 
of the cuff muscles to improve pain for up to 6 months (B). 
Subacromial infiltration can be done blindly from the anteromedial 
side as well as from the posterior, or it can be guided by ultrasound 
when done by an experienced professional (A).
Intra-articular infiltration is indicated with or without corticoids 
to improve the range of motion and pain when supplemented with 
exercises (stretching, pulley, Codman exercises, and fingerladder). 
The use of TENS (transcutaneous electrical nerve stimulator) in the 
anterior and posterior regions of the shoulder for 30 minutes 5 times 
a week at 100 Hz, 15 mA, and 150 µ-sec rise time in combination with 
these exercises can also be recommended if doing the intra-articular 
infiltration is not possible, however the infiltration shows better 
results for up to 12 weeks (A).
10. Is it recommended to use intramuscular infiltration in 
the rotator cuff syndrome?
A single posterior infiltration of the muscle on the outer edge of 
the scapula of 1 ml of triamcinolone and 1 ml of 2% mepivicaine with 
a 21 G needle revealed a partial improvement when evaluated by the 
Visual Analog Scale (VAS) (improvement from 3 to 5 points - before 
and after 7 days of treatment)30 (A).
The use of a single application of botulinum toxin at patients’ 
trigger points of those who complained of moderate to intense 
pain on a scale of 1 (no pain) to 4 (intense pain), with needles of 
27 G x 40 mm and syringes of 2.5 ml, at a depth of 1 to 3 cm, and 
a dose of 40 units of type A Botulinum Toxin per point, at 10 of 
the most active painful trigger points on unspecified muscles, with 
re-evaluations at 5, 8, and 12 weeks post-application showed that 
there was a benefit in the treatment for Myofascial Pain Syndrome, 
with an improvement in pain of 2-3 points on the pain scale used. 
Muscular infiltration with low doses of botulinum toxin, at a dose 
of 5 IU on patients with Myofascial Pain Syndrome in the region 
of the shoulder and neck, in the trapezius, the levator scapulae, 
and the infraspinatus muscles with a total dose that ranged from 
0.15 ml to 0.35 ml (containing 15 to 35 IU of the toxin) depending 
on the number of active trigger points, showed that there was 
no significant difference in the use of low doses of the botulinum 
toxin on patients with Myofascial Pain Syndrome in the cervical 
and shoulder region. For shoulder pain with trigger points on the 
infraspinatus muscle, a single muscular infiltration was done with 
50 IU/0.25 ml of botulinum toxin refrigerated to between 2 and 8oC 
using needles of 26 G x 55 mm, and pain evaluation was done using 
the Visual Analog Scale from 0 to 10 (0 = no pain and 10 = intolerable 
pain) after 4 visits with intervals of 1 week between the 1st and the 
2nd; the 3rd visit was done 3 to 5 days after the application, and the 4th 
visit 28 days after the application; there was a significant reduction 
of spontaneous and referred pain and a reduction of 3-5 points on 
the Visual Analog Scale31-33 (A).
The side effects observed were headaches and pain at the 
application site.
recommendation
A single muscular infiltration on the outer edge of the scapula of 
1 ml of triamcinolone and 1 ml of 2% mepivicaine is recommended 
to reduce the pain of patients diagnosed with tendinitis of the 
rotator cuff with a symptomology of less than 6 weeks who 
have not responded to previous medical treatment with oral 
anti-inflammatories for one week.
A single inframuscular application of type A Botulinum Toxin in 
the infraspinatus muscle with a dose of 50 IU and at another 10 most 
active painful trigger points on unspecified muscles of the scapular 
girdle at a dose of 40 IU per point is recommended to improve the 
pain of patients with rotator cuff syndrome.
11. What is the benefit of a nerve block in rotator cuff syndrome?
Blocking the suprascapular nerve (SSNB) significantly reduces 
the pain caused by tendinitis of the rotator cuff if compared with 
the usual isolated physiotherapy (p = 0.016). There is a reduction 
of pain for one week or long term after SSNB even after it has 
been metabolized and the anesthetic effect has worn off. The SSNB 
improves the performance of daily life activities (DLA) in 85% of the 
patients (p = 0.001) and the quality of sleep at night in 95% of the 
patients (p = 0.011), with NNT = 3.33 to improve the sleep hampered 
by pain. The effectiveness of the blocker was analyzed by the UCLA 
Scale for the shoulder using the chi-square test with IC = 95% and 
α = 0.05. The SSNB was done with 10 ml of 2% lidocaine in a sterile 
saline solution and the usual physiotherapy included ice, bent-over 
exercises with 5 series of 20 repetitions and exercises that progressed 
from isometrics to isotonics at different ranges of movement even in 
the presence of slight pain34 (B).
There was no statistically significant benefit of a SSNB or a 
corticosteroid infiltration in the treatment of 60 patients with 
non-specific shoulder pain. The SSNB was done with 10 ml of 1% 
lidocaine and the corticosteroid infiltration in the subacromial space 
and in the bicipital groove with 40 mg of methylprednisolone and 6 
ml of 1% lidocaine, both combined with a home exercise program. 
There was one month of monitoring and pain evaluation (measured 
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with the Visual Analog Scale), range of motion, satisfaction of the 
patient, and pain disability of the shoulder. SSNB is preferred 
over corticosteroid infiltration (CI) due to there being more 
contraindications and adverse reactions to the CI injection35 (B).
Guided by anatomical parameters, SSNB is safe and improves 
pain and functionality equally to SSNB guided by Computerized 
Tomography in patients with RCI (Rotator Cuff Injury) alone or 
associated with bicipital tendinitis, acromioclavicular arthritis, 
glenohumeral arthritis, or rheumatoid arthritis-which previously 
were submitted to treatment by oral pharmacology and/or 
intra-articular infiltration with corticosteroids. [with power of 80% 
and α = 0.05]36 (B). The SSNB represents a general patient satisfaction 
index of 7.4 (maximum = 10) even after 12 weeks36 (B).
SSNB is an effective but temporary analgesic on patients 
with tendinitis or torn rotator cuff who are not responsive to 
corticosteroidal injections in conjunction with physiotherapy, 
including mobilization exercises and physical means. SSNB with 2 
ml of a solution of 40 mg methylprednisolone and 0.5% bupivacaine 
compared with an SSNB sham with 2 ml of sterile saline solution 
reduced the night pain as much in patients with tendinitis (for 
12 weeks p < 0.02) as with torn rotator cuff (for 4 weeks p = 0.013); 
in the group with tendinitis, the ROM improved active abduction (for 
4 weeks p = 0.006), flexion (for 12 weeks p = 0.03), and outward 
rotation (for 4 weeks p = 0.02); it reduced the pain of movements in 
patients with torn rotator cuffs (for 12 weeks p = 0.004)37 (B).
recommendation
There is no level (A) evidence for the treatment of patients with 
pain from rotator cuff injuries by nerve blocks. There is no level (B) 
evidence, at least, on the treatment with nerve blocks other than 
SSNB for RCI that are not for analgesia after shoulder surgeries.
Blocking the suprascapular nerve with 5 to 10 ml of 1% lidocaine 
guided by anatomical parameters in patients with Rotator Cuff 
Syndrome with the goal of lasting analgesia (up to 12 weeks), 
improves the sleeping standards when hampered by pain, improves 
ROM, and improves functionality in the DLAs as an adjunct to 
shoulder exercise therapies (B), and, therefore, is recommended. 
The SSNB is safe, with reports only of minor local reactions as an 
adverse event following the technique of anatomical references for 
the procedure.
However important a suprascapular nerve block may be as an 
adjunct treatment in the physical reconditioning of the shoulder, 
there is no evidence-based data on its isolated effectiveness and its 
excellent periodicity of repetition. Besides, the mechanism of the 
suprascapular nerve block is not yet fully understood. Studies with 
greater scientific rigor on the blocking of the suprascapular nerve in 
patients with RCI and associated shoulder pain are necessary.
12. Does shock wave therapy benefit the treatment of rotator 
cuff syndrome?
Shock wave therapy (SWT) shows benefits in the reduction of 
pain and in improvement of shoulder mobility for those with injured 
rotator cuffs and there are various ways of applying the method. 
One session of SWT every 6 weeks or until the pain improves, for 
a maximum of 5 sessions, when done with a piezoelectric device 
focused on the area of the tendinous calcification of the shoulder 
under echo-location on patients with pain for more than 6 months 
with no improvement with at least 10 physiotherapy sessions 
experienced a diminution of type I and II tendinous calcification on 
the Gaertber & Heyer Scale. When high energy is used (1500 pulses 
and 0.44 mJ/mm2) there was an immediate pain reduction as well as 
after 6 months. With low energy (1500 pulses and 0.15 mJ/mm2) there 
was an immediate pain reduction and an 87% drop in recurrence of 
cases at 6 months (p < 0.001)38 (B).
The low energy procedure is safe (ARR: -0.067 and CI95%: -0.067 
to 0.022; NNT: 15 and CI95%: 6 to ∞) however, with high energy 
there is an increased risk of bruising (ARR: -0.194 and CI95%: -0.333 
to -0.055; NNT: 5 and CI95%: 3 to 18) observed in 19% of the cases 
(p < 0.001) and pain in 81%, and more effectiveness, for many times 
it was treated in only one session (p < 0.001) and there was no 
clinical recurrence for up to 6 months38 (B).
A total of 3 weekly sessions of SWT with a focused apparatus of 
low energy (1000 pulses and 0.08 mJ/mm2 at 4 Hz) on the shoulder 
with conventional localization (point of greatest sensitivity to the 
touch) or with radiological localization of the shoulder calcification, 
on patients with calcified tendinitis of the supraspinatus and 
shoulder pain for more than 6 months, with no improvement 
with 2 conservative treatments yielded a reduction in the pain 
and a reduction in the Visual Analog Scale (VAS), an improvement 
in functionality on the Constant and Murley Score (CMS), and an 
improvement in calcification as evaluated in shoulder radiography 
after 12 weeks of treatment. However, the improvement was 
significantly greater in the group using radiological localization on 
the VAS (p = 0.0236) as well as in the CMS (p = 0.0208)39 (B).
On patients with rotator cuff injuries with no torn tendons 
or calcification, but with pain for more than 6 months and failure 
of conservative treatments (at least 10 physiotherapy sessions, 2 
subacromial corticoid injections, and non-steroidal anti-inflammatories), 
3 weekly shock wave therapy sessions with 2000 impulses of high 
energy (0.78 mJ/mm2) or low energy (0.33 mJ/mm2) on the origin point 
of the supraspinatus tendon. There was an improvement in shoulder 
function after 12 weeks and after one year from the use of high energy 
(p < 0.001) and low energy (p = 0.006). The reduction of pain, evaluated 
by the VAS at rest, at 12 weeks, and at one year, took place after the high 
energy (p = 0.009 and p = 0.001) and low energy procedures (p < 0.001). 
However, the use of high energy reduced the pain at rest for up to one 
year (p = 0.001). Therefore, there is no significant difference between 
the use of high energy and low energy40 (B).
SWT (electromagnetic), when done 3 times (once a month) with 
1500 pulses and 0.12 mJ/mm2 using echolocation on uncalcified 
tendinitis with symptomology for more than 3 months showed no 
statistically significant reductions in pain or alleviated disability on 
the Shoulder Pain and Disability Index (SPADI) (p = 0.097)41 (B).
Another possibility is to apply shock wave therapy 
(electromagnetic) guided by fluoroscopy on patients with calcified 
tendinitis of the rotator cuff with complaints of pain for more than 3 
months and who were unresponsive to conservative treatment with 
analgesics, non-steroidal anti-inflammatories, subacromial steroid 
injections, needling of calcification, or physiotherapy. The application 
of 2500 high-energy pulses (not exceeding 0.45 mJ/mm2) in 2 sessions 
with an interval of two weeks improved functionality by 24% (CMS) 
immediately after the procedure (from 50.7 IC95%: 33.2-70.2 to 63.2 
IC95%: 23.8-90.0, p < 0.0001). Although, in the long term (after 110 
days), the use of low and high energy SWT showed improvement in 
functionality, high energy SWT is superior (t-test, p = 0.026; CI = 95% 
0.9 to 15.1) in addition to maintaining the symptomatic improvement 
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of chronic tendinitis for up to 3 months after the application. There 
were no serious adverse effects, only complaints of headaches and 
local pain when applying the high-energy SWT42 (B).
In patients with calcified tendinitis of the supraspinatus muscle 
who did not respond to conservative treatment for 6 months, the 
shock wave therapy (electro-hydraulic, 1500 pulses, and from 0.1 to 
0.13 mJ/mm2) using echolocation in 3 sessions with 2-week intervals 
improved the pain symptoms and the functionality after 24 months, 
as measured by the UCLA Scale (University of California Los Angeles) 
(from 12.38 with SD: 6.5 to 28.13 with SD: 9.34, p < 0.001) as well 
as arthroscopy for surgical removal of the calcified deposit (from 9.3 
SD: 5.2 to 30.3 SD: 7.62, p < 0.001), and as well as the improvement 
of calcification after 24 months. There is no need for anesthesia 
or hospitalization to apply SWT, therefore this therapy must be 
considered before arthroscopy for chronic calcified tendinitis of the 
shoulder43 (B).
recommendation
For the treatment of rotator cuff injuries with shock wave 
therapy, we observe significant improvements in pain symptoms, 
functionality, and in immediate and long-term calcification (1 year), 
with results no better than a placebo, and having a great variety of 
forms of application (with the majority using a focused apparatus) 
and quantity of energy (ranging from 0.1 mJ/mm2 to 0.45 mJ/mm2) 
having from 2 to 5 sessions and from 1500 to 6000 pulses and 
intervals from 1 to 2 weeks between. Still, shock wave therapy must 
be considered before arthroscopy for chronic calcified tendinitis of 
the shoulder for improvement similar to improvement of the pain, 
functionality, and calcification (B).
13. What is the benefit of using taping in rotator cuff afflictions?
Taping, which consists of wrapping self-adhesive bandages, is 
often used in the practice of rehabilitation, especially in sports, as 
much in the treatment as in the prevention of injuries.44,45 The main 
function of taping would be support during movement, however, it is 
believed that the use of some bandages can improve proprioception 
and thus diminish injuries and pain.44 The most common modality 
is non-elastic taping, however the use of elastic taping has become 
increasingly popular by professionals, and some studies are being 
conducted as to its effectiveness.
In this response we also consider studies made on professional 
athletes, since the studies on this group are the great majority.
Taping for the shoulder has demonstrated benefits concerning 
pain relief (B), but show no other benefits.
Thelen et al. demonstrated in a study made among 42 college 
students diagnosed with tendinitis of the rotator cuff and/or impact 
syndrome that the use of elastic taping immediately improved 
pain-free shoulder abduction range by 19.1º in the treatment group 
when compared to the placebo group (p = 0.05 on the first day with 
no difference after the 6th day) (B). However, the article does not 
specify whether with re-application the results are the same.45
Elastic taping must be applied by a skilled professional using 5 
cm, beige, elastic tape for two days, by the following technique:
- The first strip must be applied over the supraspinatus from 
its insertion to its origin points with the elastomeric bandage in a 
“Y” strip with tension paper off and patient with cervical inclination 
contralateral to application and the ipsilateral arm behind the back 
as if reaching the contralateral back pocket of the pants.
- The second strip, also in a “Y,” must be applied on the deltoid 
representative from its insertion with tension paper off. The first 
band of the “Y” strip must be applied to the anterior deltoid with the 
arm rotated outward and adducted 90 degrees. The second band, 
now for the posterior deltoid, must be applied with the arm still 
adducted, but now rotated inwardly.
- The third strip, approximately 20 cm in length (could be in “I” or 
in “Y” depending on size of the contours of the patient’s arm) must be 
applied from the coracoid process region to the posterior proximal 
deltoid with a manual correction in the tension at the location 
where the patient would feel pain or increased painful sensitivity 
(approximately 50% to 75% of the stretching and downward pressure 
was applied to the tape); the patient maintains the arm in outward 
rotation and when the tape is being applied distally, the patient must 
maintain shoulder flexion and slight adduction of the shoulder; at 
this moment the tape must be applied with no tension.
We must point out that the studies were conducted only for 
short periods, seeking only changes immediately after application of 
the different types of taping.
recommendation
Despite the data collected showing us that the indication of 
shoulder taping is still questionable, we recommend its application 
in rotator cuff injuries to improve the range of pain-free arm 
abduction44-47 (B). However, we suggest its application as an adjunct 
treatment, in combination with strengthening exercises of the 
rotator cuff, needing to be reapplied every three days, considering 
the response of the patient (D).
Terminology
“Y” strip: this is where the base strip is cut in the middle to make 
two bands.
“I” strip: this is where the strip is cut in the middle to make two 
bands; in other words, it is the real base strip.
Tension Paper Off: this means to apply the tape directly to the 
skin so that it comes loose from the paper on the back part - with 
approximately 15 to 20% tension.
14. What are the benefits of stretching and strengthening 
exercises in the treatment of rotator cuff syndrome?
For patients without a completely torn rotator cuff, with pain 
between 3 and 7 on the Visual Analog Scale - VAS (0-10 cm), or with 
pain in active abduction or outward rotation and positive quick-test 
for impact syndrome, the proposal is for strengthening exercises, 
passive mobilization, massage, and behavioral strategies with 
various approaches48-50 (A).
A program can be done for strengthening scapula stabilizer muscles 
for the rotator cuff, soft tissue massage, passive mobilization of the 
glenohumeral joint, scapular training, postural taping, and mobilization 
of the vertebral column, in addition to behavioral strategies with set 
goals, motivation, and positive reinforcement divided into individual 
supervised physiotherapy sessions of 30 to 45 minutes, twice a week 
for the first two weeks followed by once a week for the next four weeks, 
and then every 15 days for the last 4 weeks totaling 10 visits for 10 
weeks in the clinic. Subsequent exercises to be done at home on a daily 
basis for 12 weeks without supervision48 (A). It is expected an overall 
improvement of pain symptoms and increased strength only after the 
11th week (RRR = 27%, ARR = 0.241, NNT = 4, CI = 1.32 - 6.39)48 (A).
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Another treatment option would be 12 sessions of supervised 
rotator cuff mobilizations, application of ice to the shoulder, supervised 
strengthening and stretching of the rotator cuff muscles 3 times 
a week for 4 weeks with deep tissue massage of the supraspinatus 
muscle, neural mobilization of the radial nerve, mobilization of the 
scapula, proprioceptive neuromuscular facilitation, and techniques of 
rhythmic stabilization and relaxation. This way, improvement can be 
seen of pain symptoms on the visual analog scale from 6.7 ± 0.3 cm to 
2.0 ± 0 after treatment, and significant improvement on the range of 
motion in flexion, abduction, and lateral rotation (p < 0.05)49 (A).
Even in this group without full injuries, one can choose to do 
3 weeks of flexibility exercises on the anterior and posterior of the 
shoulder for 30 seconds: 3 repetitions with 10-second intervals 
between each repetition and 6 strengthening exercises using an elastic 
distracter for the flexor, extender, rotator, and abductor muscles 
of the shoulder and scapular muscles determined by 10 maximum 
repetitions, including manual therapy with passive mobilization of 
the joint seeking an improvement in the shoulder movement arc, 
the cervical column, and the upper thorax with an intervention of 6 
session. It is expected that this treatment will improve pain symptoms 
by 70%, functionality by 35%, and strength by 16%50 (A).
For individuals with complete tearing of the rotator cuff, the 
conservative treatment proposal may be based on educating the 
patient (activities modification), non-steroidal anti-inflammatories, 
physical modalities (ultrasound, infrared radiation, and TENS 
- Transcutaneous Electro-Neural Stimulation), and an exercise 
program. The exercise program is divided into three phases: the 
first is made up of Codman’s bent-over exercises, passive flexion 
mobilization, abduction, extension, lateral and medial rotation, and 
posterior stretching of the capsule. The second phase consists of 
strengthening exercises for the rotator cuff muscles, stabilizers of 
the scapula and deltoid using elastic distracters, and free weights. 
The last phase involves reintegrating the patients with their normal 
activities and their work, hobbies, and sports. With this proposal, a 
significant improvement in pain symptoms is seen from 20.15 ± 8.87 
to 40.00 ± 8.58 after 6 months (p < 0.001), of functionality as 
measured by ASES from 24.95 ± 10.17 to 44.15 ± 6.19 (p < 0.01) 
and of muscle strength evaluated isokinetically in the movements 
of abduction and inward and outward rotation (p = 0.01) maintained 
one year after the intervention51 (C).
The conservative treatment can be employed in place of surgery 
in specific cases such as rotator cuff syndrome combined with 
phase II of shoulder impact syndrome, also with symptoms for 
more than 3 months with no statistically significant difference. The 
conservative treatment in these cases consists of using analgesic and 
anti-inflammatory medications and exercises. It starts by suspending 
the member by a rope hanging from the ceiling to eliminate 
gravitational forces. Repeated relaxed movements are made (first, 
rotation, then flexion and extension, and finally adduction and 
abduction) for one hour every day, but supervised twice a week. On 
the other days the exercises are done at home. Resistance is added 
gradually to strengthen the shortened muscles of the rotator cuff 
and the scapula-stabilizing muscles. The training can be kept up for 3 
to 6 months with gradual lessening of supervision. In addition to this, 
motivational training must be instituted to guide the training load52 
(A). The results from the conservative and surgical treatments show 
no statistically significant difference in the improvement of pain 
symptoms and range of motion based on the Neer score (p < 0.01) 
after 2 and one-half years52 (A).
recommendation
The progressive resistance-training program for strengthening 
the rotator cuff musculature and scapula stabilizers was effective 
in reducing pain and improving functionality. Manual therapy 
combined with supervised exercising, with or without motivational 
intervention, for a period between 3 and 22 weeks, is better than 
exercise alone for increasing strength, diminishing pain, and 
improving rotator cuff function. In the treatment of class II injuries 
of the rotator cuff, no differences were found between surgery and 
supervised stretching and strengthening exercises (A).
15. Is the use of prostheses recommended in the treatment of 
rotator cuff syndrome?
Functional physiotherapy and self training compared with 
functional shoulder prosthetics (CoopercareLastrap model from 
Coopercare Inc.), used daily for an average of 12 hours for 12 
weeks, combined with guidance to avoid work and sports above the 
shoulder, has the same effectiveness in reducing pain and greater 
increase in strength than the other treatments when evaluated after 
3 months53 (B). There were no exercises associated with using the 
prosthesis.
recommendation
Using a functional prosthetic for the shoulder is an alternative in 
the treatment of rotator cuff syndrome, bringing a reduction of pain 
and an increase in strength (B).
16. When surgery is recommended, what is the best post-surgical 
treatment?
Physiotherapy after open reconstructive surgery on the rotator 
cuff, progressing in phases (initially only passive exercises to increase 
and maintain range of motion, progressing to active exercises, 
and on to strengthening exercises) shows an increased range of 
motion (ROM) and muscle strength 6 months after surgery, whether 
supervised by physiotherapists, unsupervised54 (B), or watched 
on video55 (B).
The combination of a continuing, passive, mobilization apparatus 
(4 sessions of 30 minutes in the first 4 weeks post-surgery) after 
arthroscopy to reconstruct the rotator cuff shows an improvement 
of the benefit after 6 months of monitoring when in conjunction 
with passive ROM exercises (flexion, abduction, outward rotation, 
and bent-over exercises) supervised by a physiotherapist56 (B).
When comparing the recovery of patients with torn rotator 
cuffs corrected by arthroscopy, aggressive and gradually progressive 
physiotherapy have shown a similar reduction in pain, strength 
increase, and ROM improvement after 6 months of monitoring. 
Aggressive physiotherapy uses movements to increase ROM to what 
is tolerated (begun immediately post-surgery and maintained for 
6 weeks). Gradual progressive physiotherapy uses restricted ROM 
goals that are progressively increased, using continuous passive 
mobilization apparatus (twice a day during the first 3 weeks after 
surgery). It is important to point out that the recurrence of cuff 
injuries was more significant in the aggressive approach group57 (B).
In patients with moderate to severe rotator cuff injuries submitted 
to open reconstructive surgery, the use of electrical analgesic 
stimulation (ranging from 1-2 at 60 Hz), with electrodes positioned 
at specific places (Channel A: angled above the scapula and above 
the deltoid tuberosity of the humerus; Channel B: beginning and 
ending at the suture line), starting soon after surgery and used for 
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one hour, twice a day, leads to a significant improvement in ROM 
(inward and outward rotation) of the shoulder after 90 days. Passive 
ROM exercises were included after the 8th week post-surgery58 (B).
recommendation
Physiotherapy in the post-operative period of rotator cuff 
surgeries brings an important reduction of pain and an increase of 
ROM and muscle strength to patients (B), can be done using gradual 
and progressive exercises, initially with a significant increase in 
ROM followed by muscle strengthening (B), or in an aggressive way, 
trying to attain the maximum ROM in the shortest time possible (B). 
It is important to point out that physiotherapy with an aggressive 
progression increases the risk of rupturing the corrective surgery (B).
The association of a continuous, passive mobilization apparatus 
with slow physiotherapy shows benefits when combined with 
gradually progressive physiotherapy (B).
The use of electrical stimulation of the shoulder can be used 
in combination with passive exercises for range of motion, as an 
alternate post-surgical treatment for rotator cuff syndrome (B), 
however, studies of better methodological quality concerning the 
conjunction of other therapies are necessary.
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